Shree Ganesh Remedies Ltd

NSE: SGRL · BSE: 540737 · Pharmaceuticals & Biotechnology · 7 announcements

Share price: ₹672.35
Market cap: ₹863.1 Cr
Revenue (annual): ₹109.3 Cr
Net profit (annual): ₹17.76 Cr
P/E (TTM): 55.9×Sector 50.4×
Promoter holding: 72.84%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 1 Earnings Call 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

12 Sep 2026 16:24 IST BSE

Annual General Meeting

Shree Ganesh Remedies Annual General Meeting

Shree Ganesh Remedies held its 31st Annual General Meeting on September 12, 2026. The meeting transacted ordinary and special business items, including director and auditor appointments.

Read the filing ↗

13 Aug 2026 12:34 IST BSE

Earnings Call

Shree Ganesh Remedies Investor Presentation: Key Takeaways

Q1FY27 was challenging with Revenue/PAT declining 42%/68% YoY due to subdued European demand and termination of a distributor agreement. Management shifted focus to direct customer engagement and CRAMS projects.

Open call summary → Read the filing ↗

12 Aug 2026 18:00 IST BSE

Financial Results

Shree Ganesh Remedies Q1 FY27 Results: Net Profit ₹1.1 Cr, Down 67.6% YoY

Shree Ganesh Remedies Ltd reported revenue from operations of ₹14.4 Cr (-41.7% YoY) and net profit of ₹1.1 Cr (-67.6% YoY) for Q1 FY27.

Key figure: Net profit ₹1.1 Cr · -67.6% YoY

Open full results → Read the filing ↗